List of insiders holdings for NEUROCRINE BIOSCIENCES INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Hove Anders D 10% Owner | 2010-01-05 16:08:57 | 0 4,784,689 | 4,784,689 | Form 3/A |
| 2 | ROBERTS BRYAN E 10% Owner | 2010-01-05 16:10:15 | 0 4,784,689 | 4,784,689 | Form 3/A |
| 3 | VENROCK HEALTHCARE CAPITAL PARTNERS LP VHCP Co-Investment Holdings LLC Hove Anders D ROBERTS BRYAN E VHCP Management LLC 10% Owner | 2013-02-14 16:12:40 | 2,221,946 0 | 2,221,946 | Form 13G |
| 4 | GORMAN KEVIN CHARLES Director | 2025-02-14 18:57:31 | 551,775 0 | 551,775 | Form 4 |
| 5 | Gano Kyle Chief Executive Officer | 2025-02-14 18:20:05 | 276,128 0 | 276,128 | Form 4 |
| 6 | CAMPBELL D BRUCE Senior Vice President | 2003-05-27 17:31:27 | 223,704 0 | 223,704 | Form 4 |
| 7 | Coughlin Timothy P Chief Financial Officer | 2017-02-08 19:39:04 | 137,961 0 | 137,961 | Form 4 |
| 8 | RANIERI RICHARD J Sr. VP, Human Resources | 2008-02-29 17:16:06 | 130,000 0 | 130,000 | Form 4 |
| 9 | LYONS GARY A Director | 2024-08-15 17:21:58 | 119,047 0 | 119,047 | Form 4 |
| 10 | THOMAS CYNTHIA J VP, Human Resources | 2004-03-03 17:19:48 | 113,670 0 | 113,670 | Form 3 |
| 11 | BENEVICH ERIC Chief Commercial Officer | 2025-02-14 18:03:41 | 105,567 0 | 105,567 | Form 4 |
| 12 | ABERNETHY MATT Chief Financial Officer | 2025-02-14 18:00:12 | 101,739 0 | 101,739 | Form 4 |
| 13 | Lippoldt Darin Chief Legal Officer | 2025-02-14 18:26:10 | 99,045 0 | 99,045 | Form 4 |
| 14 | ROBERTS EIRY Chief Medical Officer | 2025-02-14 18:42:06 | 98,714 0 | 98,714 | Form 4 |
| 15 | Onyia Jude Chief Scientific Officer | 2025-02-14 18:35:09 | 96,479 0 | 96,479 | Form 4 |
| 16 | OBrien Christopher Flint Former Chief Medical Officer | 2018-02-07 18:08:56 | 65,196 0 | 65,196 | Form 4 |
| 17 | Cooke Julie Chief Human Resources Officer | 2025-02-14 19:13:07 | 62,561 0 | 62,561 | Form 4 |
| 18 | CONLON PAUL J Vice President Research (Biol) | 2003-12-18 13:56:15 | 0 57,335 | 57,335 | Form 4 |
| 19 | Boyer David W. Chief Corp. Affairs Officer | 2025-02-14 18:08:11 | 52,366 0 | 52,366 | Form 4 |
| 20 | Delaet Ingrid Chief Regulatory Officer | 2025-02-14 18:13:58 | 52,205 0 | 52,205 | Form 4 |
| 21 | VALEUR JENSEN MARGARET E EVP and General Counsel | 2011-09-01 17:27:30 | 50,000 0 | 50,000 | Form 4 |
| 22 | Lloyd-Smith Malcolm Chief Integration Officer | 2023-02-08 19:35:55 | 42,337 0 | 42,337 | Form 4 |
| 23 | RASTETTER WILLIAM H Director | 2024-08-16 17:00:51 | 37,491 0 | 37,491 | Form 4 |
| 24 | Grigoriadis Dimitri E. Chief Research Officer | 2022-02-02 20:04:40 | 37,065 0 | 37,065 | Form 4 |
| 25 | WIERENGA WENDALL EVP, Research & Development | 2006-01-23 20:15:00 | 25,000 0 | 25,000 | Form 4 |
| 26 | MITCHELL W THOMAS Director | 2016-05-24 15:41:49 | 25,000 0 | 25,000 | Form 4/A |
| 27 | Gros David-Alexandre C President & COO | 2017-02-08 19:42:09 | 25,000 0 | 25,000 | Form 4 |
| 28 | PAN HENRY Executive VP and CMO | 2005-06-06 13:35:43 | 22,000 0 | 22,000 | Form 4 |
| 29 | NEUROCRINE BIOSCIENCES INC Director | 2015-04-09 16:22:08 | 16,030 0 | 16,030 | Form 4 |
| 30 | STEINMAN LAWRENCE Director | 2005-03-02 14:24:21 | 15,500 0 | 15,500 | Form 4 |
| 31 | VALE WYLIE W Director | 2011-05-25 19:13:39 | 15,000 0 | 15,000 | Form 4 |
| 32 | MOLLICA JOSEPH A Director | 2017-06-08 18:30:31 | 15,000 0 | 15,000 | Form 4 |
| 33 | LITTLE ROBERT J SVP, Commercial Operations | 2005-02-22 17:19:47 | 15,000 0 | 15,000 | Form 4 |
| 34 | Nevinny Corinne H Director | 2018-05-25 19:56:48 | 12,500 0 | 12,500 | Form 4 |
| 35 | ADAMS ADRIAN Director | 2006-06-30 17:30:18 | 12,000 0 | 12,000 | Form 4 |
| 36 | SHERWIN STEPHEN A Director | 2025-02-14 18:49:28 | 10,673 0 | 10,673 | Form 4 |
| 37 | Sandrock Alfred Director | 2019-05-23 17:46:16 | 10,000 0 | 10,000 | Form 4 |
| 38 | Mercier Johanna Director | 2024-05-23 17:59:15 | 4,417 0 | 4,417 | Form 4 |
| 39 | Norwalk Leslie V Director | 2024-05-23 18:02:27 | 4,417 0 | 4,417 | Form 4 |
| 40 | POON CHRISTINE A Director | 2024-05-23 18:45:31 | 4,417 0 | 4,417 | Form 4 |
| 41 | Sharp Shalini Director | 2024-05-23 18:34:03 | 4,417 0 | 4,417 | Form 4 |
| 42 | Bozigian Haig P. Chief Development Officer | 2021-03-29 06:12:25 | 3,504 0 | 3,504 | Form 4/A |
| 43 | SAUNDERS JOHN Vice President Research (Chem) | 2003-12-19 14:48:22 | 2,916 0 | 2,916 | Form 4 |
| 44 | MORROW GEORGE J Director | 2024-05-23 18:21:21 | 2,869 0 | 2,869 | Form 4 |
| 45 | POPS RICHARD F Director | 2024-05-23 18:26:06 | 2,869 0 | 2,869 | Form 4 |
| 46 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2013-02-14 15:26:39 | 0 0 | 0 | Form 13G |
| 47 | HAWRAN PAUL W Senior Advisor | 2006-09-20 16:33:13 | 0 0 | 0 | Form 4 |